Large-scale testing (Phase 3)Study completedNCT00238485
What this trial is testing
An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2000 mg/d in the Treatment of Manic Episodes of Bipolar I Disorder
Who this might be right for
Bipolar I Disorder
Novartis 251